Dow sets new intraday record as Moderna vaccine progress bolsters market’s least-loved shares

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

Market's least-loved stocks benefit in vaccine-news-powered rally

Stocks rose Monday after Moderna Inc. said its vaccine candidate proved highly effective in preventing COVID-19 infections, bolstering the least-loved sectors and industries as investors rotated away from shares of companies that thrived in the stay-at-home environment created by the pandemic.

Last week’s rally was inspired after Pfizer and BioNTech SE on Nov. 9 announced that their vaccine candidate was more than 90% effective in preventing COVID-19 infections in a late-stage trial. While tech shares and other stay-at-home beneficiaries lagged last week, hard-hit industries and sectors, including airlines, energy, financials and retail, benefited.

Meanwhile, investors looked past a stalled transition as President Donald Trump continued to refuse to accept the results of the Nov. 3 presidential election. In economic data, the New York Federal Reserve Bank’s Empire State index came in at a reading of 6.3 from 10.5 in October.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.

thanks

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 3. in BR

Brasil Últimas Notícias, Brasil Manchetes